Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
Phase of Trial: Phase II/III
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Apatinib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.
- 20 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
- 02 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.